GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » EV-to-Revenue

PuriBlood Medical Co (ROCO:6847) EV-to-Revenue : 11.27 (As of May. 25, 2025)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PuriBlood Medical Co's enterprise value is NT$1,247.4 Mil. PuriBlood Medical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was NT$110.7 Mil. Therefore, PuriBlood Medical Co's EV-to-Revenue for today is 11.27.

The historical rank and industry rank for PuriBlood Medical Co's EV-to-Revenue or its related term are showing as below:

ROCO:6847' s EV-to-Revenue Range Over the Past 10 Years
Min: 8.87   Med: 13.01   Max: 40.15
Current: 11.28

During the past 7 years, the highest EV-to-Revenue of PuriBlood Medical Co was 40.15. The lowest was 8.87. And the median was 13.01.

ROCO:6847's EV-to-Revenue is ranked worse than
87.2% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.7 vs ROCO:6847: 11.28

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-25), PuriBlood Medical Co's stock price is NT$90.10. PuriBlood Medical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$7.86. Therefore, PuriBlood Medical Co's PS Ratio for today is 11.46.


PuriBlood Medical Co EV-to-Revenue Historical Data

The historical data trend for PuriBlood Medical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co EV-to-Revenue Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial - 41.16 13.72 12.25 12.51

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.72 - 12.25 - 12.51

Competitive Comparison of PuriBlood Medical Co's EV-to-Revenue

For the Diagnostics & Research subindustry, PuriBlood Medical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PuriBlood Medical Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's EV-to-Revenue falls into.


;
;

PuriBlood Medical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PuriBlood Medical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1247.358/110.673
=11.27

PuriBlood Medical Co's current Enterprise Value is NT$1,247.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PuriBlood Medical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was NT$110.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PuriBlood Medical Co  (ROCO:6847) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PuriBlood Medical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=90.10/7.86
=11.46

PuriBlood Medical Co's share price for today is NT$90.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was NT$7.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PuriBlood Medical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology protects to supports living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Separation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines